Resurge Therapeutics INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersSan Jose, CA
US patents4
SAM.gov UEIX93EGWMCPEA1
CAGE code97H40
Incorporated inDE
- drug delivery therapies
- treatment
- enlarged prostate
- clinicians
- lower urinary tract symptoms
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
4 US patents granted 2023–2024, 4 of them in the five years to SEP 2025.
Pharmaceuticals 4
- Apparatus for treating Benign Prostatic HyperplasiaUS 12,090,136 · granted SEP 17, 2024
- Treatments for benign prostatic hyperplasiaUS 11,974,979 · granted MAY 7, 2024
- System and method for prostate treatmentUS 11,911,499 · granted FEB 27, 2024
- Treating benign prostatic hyperplasiaUS 11,602,516 · granted MAR 14, 2023
Granted to Resurge Therapeutics, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Resurge Therapeutics INC. | San Jose | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.